Smoltz, Penny won't change Boston's buy-low rotation plans

Leave a comment

Sean McAdam of the Boston Herald wrote a good article today about the Red Sox’s rotation plans heading into the offseason, noting that this season’s low-risk, high-reward deals for John Smoltz and Brad Penny working out poorly won’t stop general manager Theo Epstein from pursuing other pitchers with injury issues.
Here’s what Epstein had to say about Smoltz, Penny, and his offseason plans:

There’s a tendency on the heels of some of those buy-low, one-year deals not working out to go in the other direction, and say we’re not going to do that, we’re going to avoid anyone who’s coming off a bad season or anyone who’s got health concerns. But the reality is, you sign one-year, buy-low deals for a reason because a lot of them don’t work out.



But they provide you flexibility. So when they do work out, hopefully you have an option and you can keep that player for next year. If they don’t work out, you move on and you have flexibility both during that season and in future years to address needs.

Epstein went on to say that the Red Sox will likely pursue another buy-low starter to pair with Tim Wakefield at the back of a rotation fronted by Josh Beckett, Jon Lester, Daisuke Matsuzaka, and Clay Buchholz. McAdam mentions Ben Sheets as an option and calls Brandon Webb “the most interesting of those pitchers” if the Diamondbacks decline his $8.5 million option for 2010, but speculates that Rich Harden is a more likely target for the Red Sox.
Harden had a mediocre 9-9 record and 4.06 ERA for the Cubs, but led baseball with 10.9 strikeouts per nine innings and has a 3.39 career ERA. Of course, he hasn’t thrown 150 innings in a season since 2004 and has never logged 200 innings. He’s an ideal buy-low target, but my guess is that Harden is young enough and dominant enough when healthy that some team will take a multi-year, big-money gamble on him. And it won’t be Boston.

The Tigers decline Anibal Sanchez’s 2018 option

Getty Images
Leave a comment

From the “this does not surprise us in the very least” department, Tigers GM Al Avila announced today that the club is declining its $16 million option on right-hander Anibal Sanchez.

Sanchez had a terrible year in 2017, going 3-7 with a 6.41 ERA in 2017. That’s a long slide down from his 2013 season, in which he won the AL ERA title, going 14-8 and posting an ERA of 2.57 in the first year of his five-year, $80 million deal. Since then he’s gone 28-35 with a 5.15 ERA. He never started 30 games or more over the course of the contract.

The declination of the option does come with a nice parting gift for Sanchez: a $5 million buyout. Which is pretty dang high for a buyout, but that’s how the Tigers rolled three or four years ago.